According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is -2,16ย โฌ. In 2022 the company made an earnings per share (EPS) of -3,58ย โฌ an increase over its 2021 EPS that were of -4,36ย โฌ.